{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T06:38:16Z","timestamp":1768718296525,"version":"3.49.0"},"reference-count":27,"publisher":"Hindawi Limited","issue":"2","license":[{"start":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T00:00:00Z","timestamp":1481587200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T00:00:00Z","timestamp":1481587200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1111\/jcpt.12491","type":"journal-article","created":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T07:26:40Z","timestamp":1481614000000},"page":"189-194","source":"Crossref","is-referenced-by-count":13,"title":["Exploring New Zealand prescription data using sequence symmetry analyses for predicting adverse drug reactions"],"prefix":"10.1155","volume":"42","author":[{"given":"P. S.","family":"Nishtala","sequence":"first","affiliation":[{"name":"School of Pharmacy; University of Otago; Dunedin New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.-y.","family":"Chyou","sequence":"additional","affiliation":[{"name":"School of Pharmacy; University of Otago; Dunedin New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2016,12,13]]},"reference":[{"key":"10.1111\/jcpt.12491-BIB0001|jcpt12491-cit-0001","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00001648-199609000-00005","article-title":"Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis","volume":"7","author":"Hallas","year":"1996","journal-title":"Epidemiology"},{"key":"10.1111\/jcpt.12491-BIB0002|jcpt12491-cit-0002","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1046\/j.1365-2036.2000.00862.x","article-title":"Drug-induced symptoms of functional dyspepsia and nausea. A symmetry analysis of one million prescriptions","volume":"14","author":"Bytzer","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/jcpt.12491-BIB0003|jcpt12491-cit-0003","doi-asserted-by":"crossref","first-page":"A661","DOI":"10.1016\/j.jval.2015.09.2399","article-title":"Prevalence of antidepressants prescribed to tramadol users in the UK primary care setting - a prescription sequence symmetry analysis","volume":"18","author":"Chen","year":"2015","journal-title":"Value Health"},{"key":"10.1111\/jcpt.12491-BIB0004|jcpt12491-cit-0004","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/pds.1019","article-title":"Generating signals of drug-adverse effects from prescription databases and application to the risk of arrhythmia associated with antibacterials","volume":"14","author":"Corrao","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1111\/jcpt.12491-BIB0005|jcpt12491-cit-0005","doi-asserted-by":"crossref","first-page":"762","DOI":"10.5414\/CP202113","article-title":"Association of statin use with storage lower urinary tract symptoms (LUTS): data mining of prescription database","volume":"52","author":"Fujimoto","year":"2014","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1111\/jcpt.12491-BIB0006|jcpt12491-cit-0006","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/pds.3780","article-title":"Prescription sequence symmetry analysis: assessing risk, temporality, and consistency for adverse drug reactions across datasets in five countries","volume":"24","author":"Pratt","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1111\/jcpt.12491-BIB0007|jcpt12491-cit-0007","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/bcp.12696","article-title":"Cardiovascular drugs and erectile dysfunction - a symmetry analysis","volume":"80","author":"Rasmussen","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/jcpt.12491-BIB0008|jcpt12491-cit-0008","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/pds.1250","article-title":"Statins and nonsteroidal anti-inflammatory drugs - an analysis of prescription symmetry","volume":"15","author":"Silwer","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1111\/jcpt.12491-BIB0009|jcpt12491-cit-0009","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pds.1736","article-title":"Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis","volume":"18","author":"Tsiropoulos","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1111\/jcpt.12491-BIB0010|jcpt12491-cit-0010","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s40264-013-0024-z","article-title":"The effects of antitussive treatment of ACE inhibitor-induced cough on therapy compliance: a prescription sequence symmetry analysis","volume":"36","author":"Vegter","year":"2013","journal-title":"Drug Saf"},{"key":"10.1111\/jcpt.12491-BIB0011|jcpt12491-cit-0011","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1001\/archinternmed.2011.1029","article-title":"Nocturnal leg cramps and prescription use that precedes them: a sequence symmetry analysis","volume":"172","author":"Garrison","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1111\/jcpt.12491-BIB0012|jcpt12491-cit-0012","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1067\/S0190-9622(03)02087-5","article-title":"Isotretinoin and antidepressant pharmacotherapy: a prescription sequence symmetry analysis","volume":"49","author":"Hersom","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/jcpt.12491-BIB0013|jcpt12491-cit-0013","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.ijcard.2015.11.067","article-title":"\u2018Real-world\u2019 haemorrhagic rates for warfarin and dabigatran using population-level data in New Zealand","volume":"203","author":"Nishtala","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1111\/jcpt.12491-BIB0014|jcpt12491-cit-0014","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/pds.3624","article-title":"Associations of drug burden index with falls, general practitioner visits, and mortality in older people","volume":"23","author":"Nishtala","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1111\/jcpt.12491-BIB0015|jcpt12491-cit-0015","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s40266-014-0205-1","article-title":"Psychotropic medicine utilization in older people in New Zealand from 2005 to 2013","volume":"31","author":"Ndukwe","year":"2014","journal-title":"Drugs Aging"},{"key":"10.1111\/jcpt.12491-BIB0016|jcpt12491-cit-0016","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000368191","article-title":"Temporal trends in polypharmacy and hyperpolypharmacy in older New Zealanders over a 9-year period: 2005-2013","volume":"61","author":"Nishtala","year":"2015","journal-title":"Gerontology"},{"key":"10.1111\/jcpt.12491-BIB0017|jcpt12491-cit-0017","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(14)61842-0","article-title":"Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data","volume":"386","author":"Shine","year":"2015","journal-title":"Lancet"},{"key":"10.1111\/jcpt.12491-BIB0018|jcpt12491-cit-0018","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/pds.3440","article-title":"Multi-country rapid adverse drug event assessment: the Asian Pharmacoepidemiology Network (AsPEN) antipsychotic and acute hyperglycaemia study","volume":"22","author":"Pratt","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1111\/jcpt.12491-BIB0019|jcpt12491-cit-0019","doi-asserted-by":"crossref","first-page":"231651","DOI":"10.1155\/2014\/231651","article-title":"Amiodarone-induced thyrotoxic thyroiditis: a diagnostic and therapeutic challenge","volume":"2014","author":"Barvalia","year":"2014","journal-title":"Case Rep Med"},{"key":"10.1111\/jcpt.12491-BIB0020|jcpt12491-cit-0020","first-page":"U351","article-title":"The re-emergence of iodine deficiency in New Zealand?","volume":"116","author":"Mann","year":"2003","journal-title":"N Z Med J"},{"key":"10.1111\/jcpt.12491-BIB0021|jcpt12491-cit-0021","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1079\/BJN20041110","article-title":"Selenium and iodine intakes and status in New Zealand and Australia","volume":"91","author":"Thomson","year":"2004","journal-title":"Br J Nutr"},{"key":"10.1111\/jcpt.12491-BIB0022|jcpt12491-cit-0022","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s40264-013-0029-7","article-title":"Inhaled corticosteroids and the occurrence of oral candidiasis: a prescription sequence symmetry analysis","volume":"36","author":"Boven","year":"2013","journal-title":"Drug Saf"},{"key":"10.1111\/jcpt.12491-BIB0023|jcpt12491-cit-0023","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/pds.3886","article-title":"Symmetry analysis for monitoring safety of newly marketed drugs","volume":"25","author":"Kubota","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1111\/jcpt.12491-BIB0024|jcpt12491-cit-0024","unstructured":"interRAI International Collaborative interRAI Comprehensive Assessment System 2016 http:\/\/www.interrai.co.nz"},{"key":"10.1111\/jcpt.12491-BIB0025|jcpt12491-cit-0025","unstructured":"Ministry of Health, New Zealand National Minimum Dataset (Hospital Events) 2016 http:\/\/www.health.govt.nz\/nz-health-statistics\/national-collections-and-surveys\/collections\/national-minimum-dataset-hospital-events"},{"key":"10.1111\/jcpt.12491-BIB0026|jcpt12491-cit-0026","unstructured":"World Health Organization The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines http:\/\/www.cdc.gov\/nchs\/icd\/icd10cm"},{"key":"10.1111\/jcpt.12491-BIB0027|jcpt12491-cit-0027","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/pds.3508","article-title":"Case-crossover study design in pharmacoepidemiology: systematic review and recommendations","volume":"22","author":"Consiglio","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12491","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12491\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:02:36Z","timestamp":1671818556000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,13]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12491","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12,13]]}}}